يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Twenefour, Douglas"', وقت الاستعلام: 1.26s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Rubino , F , Puhl , R M , Cummings , D E , Eckel , R H , Ryan , D H , Mechanick , J I , Nadglowski , J , Ramos Salas , X , Schauer , P R , Twenefour , D , Apovian , C M , Aronne , L J , Batterham , R L , Berthoud , H R , Boza , C , Busetto , L , Dicker , D , De Groot , M , Eisenberg , D , Flint , S W , Huang , T T , Kaplan ....

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية

    المؤلفون: Twenefour, Douglas, Shields, Emma

    المصدر: Practical Diabetes ; volume 37, issue 4, page 115-120 ; ISSN 2047-2897 2047-2900

  6. 6
    دورية أكاديمية

    مصطلحات موضوعية: Medicine (General), Health Sciences

    وصف الملف: application/pdf

    العلاقة: Riddle, Matthew C.; Cefalu, William T.; Evans, Philip H.; Gerstein, Hertzel C.; Nauck, Michael A.; Oh, William K.; Rothberg, Amy E.; Roux, Carel W.; Rubino, Francesco; Schauer, Philip; Taylor, Roy; Twenefour, Douglas (2022). "Consensus report: Definition and interpretation of remission in type 2 diabetes." Diabetic Medicine (3): n/a-n/a.; https://hdl.handle.net/2027.42/171813Test; Diabetic Medicine; Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017; 40: 1631 ‐ 1640.; Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10‐year follow‐up of an open‐label, single‐centre, randomised controlled trial. Lancet. 2021; 397: 293 ‐ 304.; Rubino F, Nathan DM, Eckel RH, et al. Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016; 39: 861 ‐ 877.; Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes: 5‐year outcomes. N Engl J Med. 2017; 376: 641 ‐ 651.; White MG, Shaw JAM, Taylor R. Type 2 diabetes: the pathologic basis of reversible β‐cell dysfunction. Diabetes Care. 2016; 39: 2080 ‐ 2088.; Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009; 32: 2133 ‐ 2135.; Nagi D, Hambling C, Taylor R. Remission of type 2 diabetes: a position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS). Br J Diabetes. 2019; 19: 73 ‐ 76.; Barnes E. Between remission and cure: patients, practitioners and the transformation of leukaemia in the late twentieth century. Chronic Illn. 2007; 3: 253 ‐ 264.; Taylor R, Al‐Mrabeh A, Zhyzhneuskaya S, et al. Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery. Cell Metab. 2018; 28: 547 ‐ 556.e3Y.; Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011; 54: 2506 ‐ 2514.; Camastra S, Manco M, Mari A, et al. Beta‐cell function in severely obese type 2 diabetic patients: long‐term effects of bariatric surgery. Diabetes Care. 2007; 30: 1002 ‐ 1004.; Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care. 2007; 30: 2399 ‐ 2400.; Jeppsson J‐O, Kobold U, Barr J, et al. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002; 40: 78 ‐ 89.; EurA1c Trial Group. EurA1c: the European HbA1c trial to investigate the performance of HbA1c assays in 2166 laboratories across 17 countries and 24 manufacturers by use of the IFCC model for quality targets. Clin Chem. 2018; 64: 1183 ‐ 1192.; Bergenstal RM, Beck RW, Close KL, et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018; 41: 2275 ‐ 2280.; Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 2017; 40: 994 ‐ 999.; Shah VN, DuBose SN, Li Z, et al. Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab. 2019; 104: 4356 ‐ 4364.; Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs. 2003; 63: 1879 ‐ 1894.; Herman WH, Ratner RE. Metformin should be used to treat prediabetes in selected individuals. Diabetes Care. 2020; 43: 1988 ‐ 1990.; Davidson MB. Metformin should not be used to treat prediabetes. Diabetes Care. 2020; 43: 1983 ‐ 1987.; Yki‐Järvinen H. Glucose toxicity. Endocr Rev. 1992; 13: 415 ‐ 431.; Isaman DJ, Rothberg AE, Herman WH. Reconciliation of type 2 diabetes remission rates in studies of Roux‐en‐Y gastric bypass. Diabetes Care. 2016; 39: 2247 ‐ 2253.; Ceriello A. The emerging challenge in diabetes: the “metabolic memory”. Vascul Pharmacol. 2012; 57: 133 ‐ 138.; Murphy R, Jiang Y, Booth M, et al. Progression of diabetic retinopathy after bariatric surgery. Diabet Med. 2015; 32: 1212 ‐ 1220.; Arun CS, Pandit R, Taylor R. Long‐term progression of retinopathy after initiation of insulin therapy in Type 2 diabetes: an observational study. Diabetologia. 2004; 47: 1380 ‐ 1384.; The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998; 116: 874 ‐ 886.; Singh RP, Gans R, Kashyap SR, et al. Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes. Diabetes Care. 2015; 38: e32 ‐ e33.; Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta‐analysis. BMJ. 2020; 369: m1361.; Simmons LR, Molyneaux L, Yue DK, Chua EL. Steroid‐induced diabetes: is it just unmasking of type 2 diabetes? ISRN Endocrinol. 2012; 2012: 910905.; Li Z, Cheng Y, Wang D, et al. Incidence rate of type diabetes mellitus after gestational diabetes mellitus: a systematic review and meta‐analysis of 170,139 women. J Diab Res. 2020; 3076463.; Selvin E, Ning Y, Steffes MW, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes. 2011; 60: 298 ‐ 305.; Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010; 375: 481 ‐ 489.; Carson AP, Fox CS, McGuire DK, et al. Low hemoglobin A1c and risk of all‐cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes. 2010; 3: 661 ‐ 667.; Kramer CK, Zinman B, Retnakaran R. Short‐term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta‐analysis. Lancet Diabetes Endocrinol. 2013; 1: 28 ‐ 34.; Kramer CK, Zinman B, Choi H, Retnakaran R. Predictors of sustained drug‐free diabetes remission over 48 weeks following short‐term intensive insulin therapy in early type 2 diabetes. BMJ Open Diabetes Res Care. 2016; 4: e000270.; McInnes N, Smith A, Otto R, et al. Piloting a remission strategy in type 2 diabetes: results of a randomized controlled trial. J Clin Endocrinol Metab. 2017; 102: 1596 ‐ 1605.; Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care‐led weight‐management intervention for remission of type 2 diabetes: 2‐year results of the DiRECT open‐label, cluster‐randomised trial. Lancet Diabetes Endocrinol. 2019; 7: 344 ‐ 355.; Gregg EW, Chen H, Wagenknecht LE, et al.; Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012; 308: 2489 ‐ 2496.

  7. 7
    دورية
  8. 8
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://publications.aston.ac.uk/id/eprint/39455/1/Diabetes_UK.pdfTest; Dyson, Pamela, Twenefour, Douglas, Breen, Cathy, Duncan, Alistair, Elvin, E, Goff, Louise, Hill, Alyson, Kalsi, P, Marsland, N, McCardle, Paul, Mellor, Duane , Oliver, Lindsay and Watson, K (2018). Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine, 35 (5), pp. 541-547.

  9. 9
    دورية

    المؤلفون: TWENEFOUR, DOUGLAS

    المصدر: Nursing in Practice: The Journal for Today's Primary Care Nurse; 2015, Issue 86, p1-3, 3p